| 1 |
González-Juanatey JR, Górriz JL, Ortiz A, Valle A, Soler MJ, Facila L. Cardiorenal benefits of finerenone: protecting kidney and heart. Ann Med 2023;55:502-13. [PMID: 36719097 DOI: 10.1080/07853890.2023.2171110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Desai NR, Navaneethan SD, Nicholas SB, Pantalone KM, Wanner C, Hamacher S, Gay A, Wheeler DC. Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice. J Diabetes Complications 2023;37:108411. [PMID: 36857997 DOI: 10.1016/j.jdiacomp.2023.108411] [Reference Citation Analysis]
|
| 3 |
Zughaib M, Basharat B, Small D. A Case of STEMI-Induced Euglycemic Diabetic Ketoacidosis in a Patient Receiving a Sodium Glucose Cotransporter-2 Inhibitor. JACC: Case Reports 2023;11:101792. [DOI: 10.1016/j.jaccas.2023.101792] [Reference Citation Analysis]
|
| 4 |
Bou Daher H, Manka P, Syn WK. Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease? Dig Dis Sci 2023. [PMID: 36947290 DOI: 10.1007/s10620-023-07899-0] [Reference Citation Analysis]
|
| 5 |
Frías JP. An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program. Expert Rev Endocrinol Metab 2023;:1-20. [PMID: 36908082 DOI: 10.1080/17446651.2023.2184796] [Reference Citation Analysis]
|
| 6 |
Bailey CJ, Flatt PR, Conlon JM. An update on peptide-based therapies for type 2 diabetes and obesity. Peptides 2023;161:170939. [PMID: 36608818 DOI: 10.1016/j.peptides.2023.170939] [Reference Citation Analysis]
|
| 7 |
Dhatariya KK, Umpierrez G. Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non-critically ill adults: A call for further research. Diabet Med 2023;40:e14980. [PMID: 36256494 DOI: 10.1111/dme.14980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Miyoshi H, Matsuhisa M, Yabe D, Takahashi Y, Morimoto Y, Terauchi Y. Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study. Diabetes Ther 2023. [PMID: 36809494 DOI: 10.1007/s13300-023-01373-w] [Reference Citation Analysis]
|
| 9 |
Kurkin DV, Bakulin DA, Morkovin EI, Gorbunova YV, Strygin AV, Andriashvili TM, Sokolova AA, Bolokhov NS, Pustynnikov VE, Fomichev EA. HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS. Farm farmakol (Pâtigorsk) 2023;10:536-548. [DOI: 10.19163/2307-9266-2022-10-6-536-548] [Reference Citation Analysis]
|
| 10 |
Mishra R, Raj R, Elshimy G, Zapata I, Kannan L, Majety P, Edem D, Correa R. Adverse Events Related to Tirzepatide. J Endocr Soc 2023;7:bvad016. [PMID: 36789109 DOI: 10.1210/jendso/bvad016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Fujii M, Ohno Y, Ikeda A, Godai K, Li Y, Nakamura Y, Yabe D, Tsushita K, Kashihara N, Kamide K, Kabayama M. Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan. Hypertens Res 2023. [PMID: 36732668 DOI: 10.1038/s41440-023-01185-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Alicic RZ, Neumiller JJ, Galindo RJ, Tuttle KR. Author Response to “Insulin Dosing Safety in CKD”. Kidney International Reports 2023. [DOI: 10.1016/j.ekir.2023.01.033] [Reference Citation Analysis]
|
| 13 |
Mckee AM, Jones KE, Mcgill JB. Letter to the Editor: Insulin Dosing Safety in CKD. Kidney International Reports 2023. [DOI: 10.1016/j.ekir.2023.01.032] [Reference Citation Analysis]
|
| 14 |
Esposito S, Rosafio C, Antodaro F, Argentiero A, Bassi M, Becherucci P, Bonsanto F, Cagliero A, Cannata G, Capello F, Cardinale F, Chiriaco T, Consolaro A, Dessì A, Di Mauro G, Fainardi V, Fanos V, Guarino A, Li Calzi G, Lodi E, Maghnie M, Manfredini L, Malorgio E, Minuto N, Modena MG, Montori R, Moscatelli A, Patrone E, Pescio E, Poeta M, Ravelli A, Spelta M, Suppiej A, Vai S, Villa L, Zanini R, Botti R, Gaddi AV. Use of Telemedicine Healthcare Systems in Children and Adolescents with Chronic Disease or in Transition Stages of Life: Consensus Document of the Italian Society of Telemedicine (SIT), of the Italian Society of Preventive and Social Pediatrics (SIPPS), of the Italian Society of Pediatric Primary Care (SICuPP), of the Italian Federation of Pediatric Doctors (FIMP) and of the Syndicate of Family Pediatrician Doctors (SIMPeF). J Pers Med 2023;13. [PMID: 36836469 DOI: 10.3390/jpm13020235] [Reference Citation Analysis]
|
| 15 |
Esposito S, Rosafio C, Antodaro F, Argentiero A, Bassi M, Becherucci P, Bonsanto F, Cagliero A, Cannata G, Capello F, Cardinale F, Chiriaco T, Consolaro A, Dessì A, Di Mauro G, Fainardi V, Fanos V, Guarino A, Li Calzi G, Lodi E, Maghnie M, Manfredini L, Malorgio E, Minuto N, Modena MG, Montori R, Moscatelli A, Patrone E, Pescio E, Poeta M, Ravelli A, Spelta M, Suppiej A, Vai S, Villa L, Zanini R, Botti R, Gaddi AV. Use of Telemedicine Healthcare Systems in Pediatric Assistance at Territorial Level: Consensus Document of the Italian Society of Telemedicine (SIT), of the Italian Society of Preventive and Social Pediatrics (SIPPS), of the Italian Society of Pediatric Primary Care (SICuPP), of the Italian Federation of Pediatric Doctors (FIMP) and of the Syndicate of Family Pediatrician Doctors (SIMPeF). J Pers Med 2023;13. [PMID: 36836432 DOI: 10.3390/jpm13020198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Majait S, Nieuwdorp M, Kemper M, Soeters M. The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor? Int J Mol Sci 2023;24. [PMID: 36768140 DOI: 10.3390/ijms24031816] [Reference Citation Analysis]
|
| 17 |
Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, Ionescu R, Jinga M, Sirbu CA. Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. Metabolites 2023;13. [PMID: 36677012 DOI: 10.3390/metabo13010087] [Reference Citation Analysis]
|
| 18 |
Tamargo J. How important it is to know the preferences of the diabetic patient. Int J Cardiol 2023;370:425-6. [PMID: 36243180 DOI: 10.1016/j.ijcard.2022.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Tangpricha V. Message from the Editor in Chief of Endocrine Practice: Celebrating 28 Years! Endocr Pract 2023;29:1. [PMID: 36608986 DOI: 10.1016/j.eprac.2022.12.002] [Reference Citation Analysis]
|
| 20 |
Simões de Carvalho F, de Brito Marques F, Lopes AE, Lima Ferreira J, Príncipe RM. Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal Protection in Type 2 Diabetes) Cross-Sectional Study. Cureus 2023;15:e33509. [PMID: 36628395 DOI: 10.7759/cureus.33509] [Reference Citation Analysis]
|
| 21 |
Wright WL, Urquhart S, Brunton S. Beyond Blood Glucose and Blood Pressure Control in Type 2 Diabetes: Alternative Management Strategies to Prevent the Development and Progression of CKD. J Prim Care Community Health 2023;14:21501319231153599. [PMID: 36935560 DOI: 10.1177/21501319231153599] [Reference Citation Analysis]
|
| 22 |
Morgentaler A, Traish A, Barua RS, Dandona P, Dhindsa S, Khera M, Saad F. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther 2022;3:217-23. [PMID: 36643964 DOI: 10.1089/andro.2022.0021] [Reference Citation Analysis]
|
| 23 |
Tan SJ, Baharin B, Mohd N, Nabil S. Effect of Anti-Diabetic Medications on Dental Implants: A Scoping Review of Animal Studies and Their Relevance to Humans. Pharmaceuticals (Basel) 2022;15. [PMID: 36558969 DOI: 10.3390/ph15121518] [Reference Citation Analysis]
|
| 24 |
Popescu AD, Carsote M, Valea A, Nicola AG, Dascălu IT, Tircă T, Abdul-Razzak J, Țuculină MJ. Approach of Acromegaly during Pregnancy. Diagnostics (Basel) 2022;12. [PMID: 36359512 DOI: 10.3390/diagnostics12112669] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
